Celligenics is a biotechnology company specialised in the development of future-relevant solutions through stem cell technology in a new era of regenerative medicine. Celligenics aims to be a global leader in the innovative isolation and application of human stem cells and its derivatives, and to empower humanity with unprecedented regenerative healthcare solutions that will enhance the quality of human life. Celligenics possesses strong credentials in the dual-facet of enterprise development and scientific research. The collective team has core expertise in enterprise strategy, investment finance, research & development, as well as experience in the field of working with molecular and cell biology.
| Website | http://www.celligenics.com/ |
| Employees | 8 (3 on RocketReach) |
| Founded | 2016 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+7 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Clinical Trials, Stem Cell Therapy, Pharmaceutical Research, Regenerative Medicine, Cell Therapy, Biotechnology, Stem Cell Research, Cellular Therapy, Regenerative Treatments, Stem Cell Applications, Cell Based Therapy, Innovative Therapies, Future Medicine, Advanced Therapies, Cell Isolation, Tissue Regeneration, Cellular Regeneration, Therapeutic Applications, Biomedical Research |
| Competitors | Thermo Fisher Scientific, Lonza, Verily, STEMCELL Technologies, CureVac, Zymergen, Inc., Athersys, ESCO ASTER PTE LTD, Cellerant Therapeutics, Regenetech Inc +41 more (view full list) |
Looking for a particular Celligenics employee's phone or email?
John Dangerfield is the Senior Director of Celligenics.
3 people are employed at Celligenics.